All trades / TELA
TELA
TELA Bio, Inc.
258Open-market trades
+9.64%Avg 90d after buys
+17.7%Avg 90d after sales
+11.0%Avg 180d after buys
Price and insider prints
TELA adjusted close▲ buy▼ sale
Trades
| Date | Form 4 | Ticker | Insider | Title | Side | Shares | Value | 90d | 180d |
|---|---|---|---|---|---|---|---|---|---|
| 9/17/2026 | Form 4 | TELA | Capper Joseph HMr. Capper has served on the board of directors of Anika Therapeutics, Inc. (NASDAQ: ANIK), since May 2024. He received his undergraduate degree in Accounting from West Chester University and an MBA in International Finance from George Washington University. Skills & Qualifications : Mr. Capper’s expertise in the medical device industry and experience as an executive officer in the medical device field provide him with the qualifications and skills to serve on our Board. 8 | Notice of Annual Meeting of Stockholders and 2026 Proxy Statement | Director | BUY | 25,000 | $30.5K | +18.4%hist | +32.0%hist |
| 9/16/2026 | Form 4 | TELA | Capper Joseph HMr. Capper has served on the board of directors of Anika Therapeutics, Inc. (NASDAQ: ANIK), since May 2024. He received his undergraduate degree in Accounting from West Chester University and an MBA in International Finance from George Washington University. Skills & Qualifications : Mr. Capper’s expertise in the medical device industry and experience as an executive officer in the medical device field provide him with the qualifications and skills to serve on our Board. 8 | Notice of Annual Meeting of Stockholders and 2026 Proxy Statement | Director | BUY | 50,000 | $58.3K | +18.4%hist | +32.0%hist |
| 9/15/2026 | Form 4 | TELA | Capper Joseph HMr. Capper has served on the board of directors of Anika Therapeutics, Inc. (NASDAQ: ANIK), since May 2024. He received his undergraduate degree in Accounting from West Chester University and an MBA in International Finance from George Washington University. Skills & Qualifications : Mr. Capper’s expertise in the medical device industry and experience as an executive officer in the medical device field provide him with the qualifications and skills to serve on our Board. 8 | Notice of Annual Meeting of Stockholders and 2026 Proxy Statement | Director | BUY | 50,000 | $52.9K | +18.4%hist | +32.0%hist |
| 9/14/2026 | Form 4 | TELA | Capper Joseph HMr. Capper has served on the board of directors of Anika Therapeutics, Inc. (NASDAQ: ANIK), since May 2024. He received his undergraduate degree in Accounting from West Chester University and an MBA in International Finance from George Washington University. Skills & Qualifications : Mr. Capper’s expertise in the medical device industry and experience as an executive officer in the medical device field provide him with the qualifications and skills to serve on our Board. 8 | Notice of Annual Meeting of Stockholders and 2026 Proxy Statement | Director | BUY | 25,000 | $25.5K | +18.4%hist | +32.0%hist |
| 8/17/2026 | Form 4 | TELA | Getz Heather C | Chief Executive Officer | BUY | 12,500 | $8.3K | +14.9%hist | +7.49%hist |
| 8/14/2026 | Form 4 | TELA | Getz Heather C | Chief Executive Officer | BUY | 15,000 | $10.5K | +14.9%hist | +7.49%hist |
| 11/17/2025 | Form 4 | TELA | EW HEALTHCARE PARTNERS FUND 2, L.P. · EW HEALTHCARE PARTNERS FUND 2-A, L.P. · EW Healthcare Partners Fund 2 GP, L.P. · EW Healthcare Partners Fund 2-UGP, LLC | 10% owner | BUY | 3,604,000 | $4.00M | −32.8% | −27.2% |
| 10/24/2024 | Form 4 | TELA | KOBLISH ANTONY | Chief Executive Officer | BUY | 88,888 | $200.0K | +3.49% | −63.6% |
| 10/24/2024 | Form 4 | TELA | Talmo PaulPaul Talmo has served as our Chief Technology Officer since August 2023. Prior to this, Mr. Talmo served in roles of increasing responsibility at the Company since 2017, including serving as our Chief Strategic Officer. Mr. Talmo has over 25 years of experience commercializing technologies within the medical device and service industries, including medical devices, implantable materials, as well as imaging and diagnostic technologies services. Prior to joining TELA, Mr. Talmo also spent 16 years at LifeCell Corporation, a regenerative medicine company which was acquired by Allergan plc in February 2017, and was an impetus behind the transformation of a burn focused company into a soft tissue reconstruction… | Chief Technology Officer | BUY | 22,222 | $50.0K | +3.49% | −63.6% |
| 10/24/2024 | Form 4 | TELA | Cuca RobertoRoberto Cuca has served as our Chief Operating Officer and Chief Financial Officer since September 2021 and Corporate Secretary since August 2025. Previously, Mr. Cuca served as Senior Advisor of OraSure Technologies, Inc., or OraSure, a point-of-care testing and sample collection technologies company, from May 2018 to June 2018 and as the Chief Financial Officer from June 2018 to September 2021. Before joining OraSure, Mr. Cuca served as Senior Vice President and Chief Financial Officer of Trevena, Inc., a clinical stage biopharmaceutical company, from September 2013 to May 2018, where he led the finance and investor relations functions and worked with senior management to establish and execute overall… | COO and CFO | BUY | 64,444 | $145.0K | +3.49% | −63.6% |
| 10/24/2024 | Form 4 | TELA | Firestone Gregory A. | Chief Commercial Officer | BUY | 6,666 | $15.0K | +3.49% | −63.6% |
| 7/2/2024 | Form 4 | TELA | ORBIMED ADVISORS LLC · OrbiMed Capital GP IV LLC | 10% owner | SELL | 36,600 | $166.2K | +45.1% | +37.1% |
| 7/1/2024 | Form 4 | TELA | ORBIMED ADVISORS LLC · OrbiMed Capital GP IV LLC | 10% owner | SELL | 13,700 | $64.1K | +43.7% | +35.4% |
| 6/28/2024 | Form 4 | TELA | ORBIMED ADVISORS LLC · OrbiMed Capital GP IV LLC | 10% owner | SELL | 378,000 | $1.79M | +44.3% | +37.9% |
| 12/5/2023 | Form 4 | TELA | Firestone Gregory A. | Chief Business Officer | BUY | 2,600 | $14.7K | +27.3% | +0.92% |
| 11/14/2023 | Form 4 | TELA | KOBLISH ANTONY | Chief Executive Officer | BUY | 11,000 | $49.9K | +64.3% | +27.8% |
| 11/14/2023 | Form 4 | TELA | Cuca RobertoRoberto Cuca has served as our Chief Operating Officer and Chief Financial Officer since September 2021 and Corporate Secretary since August 2025. Previously, Mr. Cuca served as Senior Advisor of OraSure Technologies, Inc., or OraSure, a point-of-care testing and sample collection technologies company, from May 2018 to June 2018 and as the Chief Financial Officer from June 2018 to September 2021. Before joining OraSure, Mr. Cuca served as Senior Vice President and Chief Financial Officer of Trevena, Inc., a clinical stage biopharmaceutical company, from September 2013 to May 2018, where he led the finance and investor relations functions and worked with senior management to establish and execute overall… | COO and CFO | BUY | 10,000 | $44.9K | +64.3% | +27.8% |
| 4/21/2023 | Form 4 | TELA | ORBIMED ADVISORS LLC · OrbiMed Capital GP IV LLC | 10% owner | SELL | 27,700 | $260.7K | −8.96% | +38.3% |
| 4/20/2023 | Form 4 | TELA | ORBIMED ADVISORS LLC · OrbiMed Capital GP IV LLC | 10% owner | SELL | 28,300 | $266.9K | −9.94% | +35.0% |
| 4/19/2023 | Form 4 | TELA | ORBIMED ADVISORS LLC · OrbiMed Capital GP IV LLC | 10% owner | SELL | 136,000 | $1.26M | −8.88% | +33.2% |
| 11/3/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 19,000 | $148.4K | +45.9% | +20.3% |
| 11/3/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 1,262 | $9.9K | +45.9% | +20.3% |
| 10/11/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 15,000 | $120.0K | +44.3% | +35.6% |
| 10/11/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 1,000 | $8.0K | +44.3% | +35.6% |
| 9/23/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 6,500 | $51.9K | +33.1% | +22.3% |
| 9/23/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 304 | $2.4K | +33.1% | +22.3% |
| 9/19/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 1,000 | $8.1K | +20.2% | +25.8% |
| 9/19/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 17,000 | $137.5K | +20.2% | +25.8% |
| 9/16/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 2,000 | $16.2K | +28.5% | +14.1% |
| 9/16/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 372 | $3.0K | +28.5% | +14.1% |
| 9/15/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 3,500 | $28.4K | +26.9% | +14.9% |
| 9/15/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 658 | $5.3K | +26.9% | +14.9% |
| 8/17/2022 | Form 4 | TELA | EW HEALTHCARE PARTNERS FUND 2, L.P. · EW HEALTHCARE PARTNERS FUND 2-A, L.P. · EW Healthcare Partners Fund 2 GP, L.P. · EW Healthcare Partners Fund 2-UGP, LLC | Other | BUY | 500,000 | $4.00M | −2.76% | +35.2% |
| 8/16/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 221 | $1.8K | −2.58% | +38.5% |
| 8/16/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 5,000 | $40.5K | −2.58% | +38.5% |
| 8/16/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 300,000 | $2.40M | −2.58% | +38.5% |
| 8/16/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 15,000 | $120.0K | −2.58% | +38.5% |
| 8/10/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 479 | $4.1K | −16.7% | +35.6% |
| 8/10/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 11,500 | $98.0K | −16.7% | +35.6% |
| 8/1/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 4,500 | $35.8K | +11.5% | +44.1% |
| 8/1/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 479 | $3.8K | +11.5% | +44.1% |
| 8/1/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 4,500 | $35.8K | +11.5% | +44.1% |
| 8/1/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 479 | $3.8K | +11.5% | +44.1% |
| 7/22/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 200 | $1.6K | +7.00% | +47.5% |
| 7/22/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 5,000 | $40.1K | +7.00% | +47.5% |
| 7/21/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 833 | $6.7K | +5.45% | +48.9% |
| 7/21/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 9,500 | $76.3K | +5.45% | +48.9% |
| 7/20/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 600 | $4.8K | +6.06% | +48.8% |
| 7/20/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 4,500 | $36.4K | +6.06% | +48.8% |
| 7/14/2022 | Form 4 | TELA | EW HEALTHCARE PARTNERS FUND 2, L.P. · EW HEALTHCARE PARTNERS FUND 2-A, L.P. · EW Healthcare Partners Fund 2 GP, L.P. · EW Healthcare Partners Fund 2-UGP, LLC | 10% owner | BUY | 5,000 | $40.0K | +2.13% | +32.5% |
| 7/13/2022 | Form 4 | TELA | EW HEALTHCARE PARTNERS FUND 2, L.P. · EW HEALTHCARE PARTNERS FUND 2-A, L.P. · EW Healthcare Partners Fund 2 GP, L.P. · EW Healthcare Partners Fund 2-UGP, LLC | Other | BUY | 5,000 | $40.1K | +1.12% | +45.9% |
| 7/12/2022 | Form 4 | TELA | EW HEALTHCARE PARTNERS FUND 2, L.P. · EW HEALTHCARE PARTNERS FUND 2-A, L.P. · EW Healthcare Partners Fund 2 GP, L.P. · EW Healthcare Partners Fund 2-UGP, LLC | Other | BUY | 5,000 | $40.1K | +1.00% | +46.5% |
| 7/11/2022 | Form 4 | TELA | EW HEALTHCARE PARTNERS FUND 2, L.P. · EW HEALTHCARE PARTNERS FUND 2-A, L.P. · EW Healthcare Partners Fund 2 GP, L.P. · EW Healthcare Partners Fund 2-UGP, LLC | Other | BUY | 5,000 | $40.1K | +1.51% | +47.2% |
| 7/8/2022 | Form 4 | TELA | EW HEALTHCARE PARTNERS FUND 2, L.P. · EW HEALTHCARE PARTNERS FUND 2-A, L.P. · EW Healthcare Partners Fund 2 GP, L.P. · EW Healthcare Partners Fund 2-UGP, LLC | Other | BUY | 5,000 | $39.8K | +11.2% | +48.6% |
| 7/7/2022 | Form 4 | TELA | EW HEALTHCARE PARTNERS FUND 2, L.P. · EW HEALTHCARE PARTNERS FUND 2-A, L.P. · EW Healthcare Partners Fund 2 GP, L.P. · EW Healthcare Partners Fund 2-UGP, LLC | Other | BUY | 5,000 | $40.4K | +12.7% | +44.1% |
| 7/6/2022 | Form 4 | TELA | EW HEALTHCARE PARTNERS FUND 2, L.P. · EW HEALTHCARE PARTNERS FUND 2-A, L.P. · EW Healthcare Partners Fund 2 GP, L.P. · EW Healthcare Partners Fund 2-UGP, LLC | Other | BUY | 5,000 | $39.3K | +16.7% | +49.7% |
| 7/5/2022 | Form 4 | TELA | EW HEALTHCARE PARTNERS FUND 2, L.P. · EW HEALTHCARE PARTNERS FUND 2-A, L.P. · EW Healthcare Partners Fund 2 GP, L.P. · EW Healthcare Partners Fund 2-UGP, LLC | Other | BUY | 5,000 | $37.6K | +12.3% | +51.5% |
| 7/1/2022 | Form 4 | TELA | EW HEALTHCARE PARTNERS FUND 2, L.P. · EW HEALTHCARE PARTNERS FUND 2-A, L.P. · EW Healthcare Partners Fund 2 GP, L.P. · EW Healthcare Partners Fund 2-UGP, LLC | Other | BUY | 5,000 | $36.4K | +12.9% | +54.9% |
| 7/1/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 200 | $1.4K | +12.9% | +54.9% |
| 6/30/2022 | Form 4 | TELA | EW HEALTHCARE PARTNERS FUND 2, L.P. · EW HEALTHCARE PARTNERS FUND 2-A, L.P. · EW Healthcare Partners Fund 2 GP, L.P. · EW Healthcare Partners Fund 2-UGP, LLC | Other | BUY | 5,000 | $35.4K | +21.0% | +57.6% |
| 6/30/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 2,998 | $21.0K | +21.0% | +57.6% |
| 6/30/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 567 | $4.0K | +21.0% | +57.6% |
| 6/29/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 2 | $13.98 | +17.8% | +56.5% |
| 6/28/2022 | Form 4 | TELA | EW HEALTHCARE PARTNERS FUND 2, L.P. · EW HEALTHCARE PARTNERS FUND 2-A, L.P. · EW Healthcare Partners Fund 2 GP, L.P. · EW Healthcare Partners Fund 2-UGP, LLC | Other | BUY | 5,000 | $35.5K | +16.2% | +57.2% |
| 6/28/2022 | Form 4 | TELA | EW HEALTHCARE PARTNERS FUND 2, L.P. · EW HEALTHCARE PARTNERS FUND 2-A, L.P. · EW Healthcare Partners Fund 2 GP, L.P. · EW Healthcare Partners Fund 2-UGP, LLC | Other | BUY | 5,000 | $35.5K | +16.2% | +57.2% |
| 6/27/2022 | Form 4 | TELA | EW HEALTHCARE PARTNERS FUND 2, L.P. · EW HEALTHCARE PARTNERS FUND 2-A, L.P. · EW Healthcare Partners Fund 2 GP, L.P. · EW Healthcare Partners Fund 2-UGP, LLC | Other | BUY | 5,000 | $36.1K | +12.7% | +52.4% |
| 6/24/2022 | Form 4 | TELA | EW HEALTHCARE PARTNERS FUND 2, L.P. · EW HEALTHCARE PARTNERS FUND 2-A, L.P. · EW Healthcare Partners Fund 2 GP, L.P. · EW Healthcare Partners Fund 2-UGP, LLC | Other | BUY | 5,000 | $35.3K | +15.7% | +52.6% |
| 6/23/2022 | Form 4 | TELA | EW HEALTHCARE PARTNERS FUND 2, L.P. · EW HEALTHCARE PARTNERS FUND 2-A, L.P. · EW Healthcare Partners Fund 2 GP, L.P. · EW Healthcare Partners Fund 2-UGP, LLC | Other | BUY | 5,000 | $35.0K | +17.0% | +49.0% |
| 6/22/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 50,000 | $325.0K | +29.2% | +53.5% |
| 6/22/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 400 | $2.8K | +29.2% | +53.5% |
| 6/22/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 2,000 | $14.0K | +29.2% | +53.5% |
| 6/22/2022 | Form 4 | TELA | EW HEALTHCARE PARTNERS FUND 2, L.P. · EW HEALTHCARE PARTNERS FUND 2-A, L.P. · EW Healthcare Partners Fund 2 GP, L.P. · EW Healthcare Partners Fund 2-UGP, LLC | Other | BUY | 5,000 | $32.4K | +29.2% | +53.5% |
| 6/21/2022 | Form 4 | TELA | EW HEALTHCARE PARTNERS FUND 2, L.P. · EW HEALTHCARE PARTNERS FUND 2-A, L.P. · EW Healthcare Partners Fund 2 GP, L.P. · EW Healthcare Partners Fund 2-UGP, LLC | Other | BUY | 5,000 | $31.3K | +36.1% | +63.6% |
| 6/17/2022 | Form 4 | TELA | EW HEALTHCARE PARTNERS FUND 2, L.P. · EW HEALTHCARE PARTNERS FUND 2-A, L.P. · EW Healthcare Partners Fund 2 GP, L.P. · EW Healthcare Partners Fund 2-UGP, LLC | Other | BUY | 5,000 | $30.9K | +39.8% | +77.4% |
| 6/16/2022 | Form 4 | TELA | EW HEALTHCARE PARTNERS FUND 2, L.P. · EW HEALTHCARE PARTNERS FUND 2-A, L.P. · EW Healthcare Partners Fund 2 GP, L.P. · EW Healthcare Partners Fund 2-UGP, LLC | Other | BUY | 5,000 | $30.1K | +34.7% | +75.0% |
| 6/15/2022 | Form 4 | TELA | EW HEALTHCARE PARTNERS FUND 2, L.P. · EW HEALTHCARE PARTNERS FUND 2-A, L.P. · EW Healthcare Partners Fund 2 GP, L.P. · EW Healthcare Partners Fund 2-UGP, LLC | Other | BUY | 5,000 | $29.5K | +39.4% | +84.1% |
| 6/14/2022 | Form 4 | TELA | EW HEALTHCARE PARTNERS FUND 2, L.P. · EW HEALTHCARE PARTNERS FUND 2-A, L.P. · EW Healthcare Partners Fund 2 GP, L.P. · EW Healthcare Partners Fund 2-UGP, LLC | Other | BUY | 5,000 | $29.3K | +48.8% | +87.9% |
| 6/13/2022 | Form 4 | TELA | EW HEALTHCARE PARTNERS FUND 2, L.P. · EW HEALTHCARE PARTNERS FUND 2-A, L.P. · EW Healthcare Partners Fund 2 GP, L.P. · EW Healthcare Partners Fund 2-UGP, LLC | Other | BUY | 5,000 | $29.0K | +46.5% | +85.1% |
| 6/10/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 2,500 | $14.0K | +55.5% | +66.6% |
| 6/10/2022 | Form 4 | TELA | Opaleye Management Inc. | 10% owner | BUY | 25,000 | $140.0K | +55.5% | +66.6% |
Chart shows split-adjusted close for the last three years, or the selected date range. Triangles mark open-market Form 4 purchases and sales in that window.